L-798106 is a selective antagonist for the calcitonin gene-related peptide (CGRP) receptor. It is primarily used in scientific research to study the role of CGRP in physiological and pathological processes. This compound is valuable in neuroscience and pharmacology for investigating migraine mechanisms, as CGRP is strongly implicated in migraine pathophysiology. By blocking CGRP receptors, L-798106 helps researchers understand receptor function and signaling pathways involved in pain transmission and neurogenic inflammation. It is also used in preclinical studies to evaluate potential therapeutic strategies for migraine and other pain-related conditions, supporting the development of new classes of antimigraine drugs.